Evidence map›Paper›PMID 39949724›Full record

ReviewFrontiers in cardiovascular medicine2024

Rethinking mechanical heart valves in the aortic position: new paradigms in design and testing.

Sreyashi Chakraborty, Melinda G Simon, Alessandro Bellofiore

Abstract readReview
In one paragraph

Review in Frontiers in cardiovascular medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sreyashi ChakrabortyBiomedical Engineering Department, San José State University, San Jose, CA, United States.
Melinda G SimonBiomedical Engineering Department, San José State University, San Jose, CA, United States.
Alessandro BellofioreBiomedical Engineering Department, San José State University, San Jose, CA, United States.

Funding

A comprehensive testing platform for mechanical heart valves to propel innovation towards anticoagulant-independenceSC1HL155056 · NHLBI · SAN JOSE STATE UNIVERSITY · PI BELLOFIORE, ALESSANDRO · 2020 to 2023
$1.1M
NHLBI NIH HHS SC1 HL155056
6 · The paper itself

Abstract

Bileaflet mechanical heart valves (MHV) remain a viable option for aortic valve replacement, particularly for younger patients and patients from low- and middle-income countries and underserved communities. Despite their exceptional durability, MHV recipients are at increased risk of thromboembolic complications. As such, the development of the next generation of MHVs must prioritize improved thromboresistance and aim for independence from anticoagulant therapy. However, innovation in MHV design faces several challenges: strict performance and biocompatibility requirements, limited understanding of the mechanisms underlying MHV thrombosis, and a lack of effective testing methodologies to assess how design variations impact both hemodynamic performance and thrombogenicity of MHVs. This paper reviews the emerging paradigms in MHV design, materials and surface modifications that may inspire the development of a new generation of MHVs for aortic valve replacement. We also discuss challenges and opportunities in developing experimental and numerical approaches to achieve a more comprehensive understanding of MHV flow features and the mechanisms of flow-induced blood clotting.

Indexed as

aortic valve replacementhemodynamicsmechanical heart valvesparticle image velocimetrythrombogenicity

Identifiers

PMID39949724
PMCPMC11822478

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.